Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Feb 06 2025

· Issued by Oxygenta Pharmaceutical Limited via BSE India

Filed with BSE ·

Mark Corporate Advisors Pvt Ltd. ("Manager to the Offer") has submitted to BSE a copy of Offer Opening Public Announcement under Regulation 18(7) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended, for the attention of the eligible equity shareholders of Oxygenta Pharmaceutical Ltd ("the Company").

View Attachment

6ix hasn’t read this filing yet.

Oxygenta Pharmaceutical Limited on 6ix

Earlier from Oxygenta Pharmaceutical

Later from Oxygenta Pharmaceutical

All Oxygenta Pharmaceutical news releases